Colchicine for the prevention of vascular events after non-cardioembolic stroke
- PMID: 38857610
- DOI: 10.1016/S0140-6736(24)01096-1
Colchicine for the prevention of vascular events after non-cardioembolic stroke
Conflict of interest statement
AHK and AS serve as co-principal investigators for the CoVasc-ICH trial (NCT05159219), funded by the Canadian Institutes of Health Research. AHK serves as an adjudication committee member and AS as the co-principal investigator for the OCEANIC-STROKE trial (NCT05686070), funded by Bayer.
Comment on
-
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.Lancet. 2024 Jul 13;404(10448):125-133. doi: 10.1016/S0140-6736(24)00968-1. Epub 2024 Jun 7. Lancet. 2024. PMID: 38857611 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical